Keywords: scios, nova, fiblast, news, presented, preclinical, evidence

Scios Nova: Fiblast news

Article | 05 February 1996

Print This

- Scios Nova has presented preclinical evidence that its basic fibroblast growth factor product Fiblast (trofermin) may be effective in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in